Literature DB >> 26675939

Endoscopic revision of gastric bypass: Holy Grail or Epic fail?

Alberto S Gallo1,2, Christopher G DuCoin3, Martin A Berducci3, Diego F Nino3, Moneer Almadani3, Bryan J Sandler3, Santiago Horgan3, Garth R Jacobsen3.   

Abstract

BACKGROUND: Approximately 20-30 % of patients who undergo Roux-en-Y gastric bypass (RYGB) will not meet the goals of weight loss surgery. Revisional surgery is associated with higher morbidity compared to initial operative management, and results in terms of weight loss have been inconsistent. Endoscopic plication has been seen as a less invasive option, with encouraging initial results. The objective was to analyze the outcomes after Restorative Obesity Surgery, Endolumenal (ROSE) procedure.
METHODS: We retrospectively analyzed patients who underwent ROSE between 5/2008 and 11/2013. All patients had failure of weight loss or regain weight after RYGB. Demographics, operative data, and follow-up were recorded.
RESULTS: Twenty-seven patients underwent ROSE. One patient was excluded due to lack of follow-up. Twenty-five (96 %) patients were female. Mean time since initial RYGB was 11.9 ± 4.3 years. Mean initial weight and BMI were 236 ± 47 lb and 40.6 ± 8.1 kg/m(2), respectively. Mean OR time was 77 ± 30 min. Preoperative average pouch length and stoma diameter were 6.8 ± 2.3 and 2.1 ± 0.7 cm, respectively. On average, 4 ± 1.6 stitches were placed. Final pouch length and stoma diameter were 3.4 ± 1.6 (50 % reduction) and 0.86 ± 0.4 cm (61 % reduction). A total of 12 (46 %) and seven (28 %) patients underwent EGD at 3 and 12 months postoperatively. The mean pouch length and stoma diameter were 5 ± 1.9 (26.5 % reduction) and 1.2 ± 0.7 cm (42.9 % reduction) at 3 months and 6.14 ± 1.6 (10 % reduction) and 2.2 ± 1.2 cm (4.7 % increase) at 12 months, respectively. The %EWL was 8.9, 9.3, 8, 6.7, -10.7, -13.5, -5.8, -4.5 at 3, 6, 12, 24, 36, 48, 60, and 72 months, respectively.
CONCLUSION: Although endoscopic plication achieved the intended reduction in the pouch and stoma diameter at 3 months, these tend toward the preoperative diameter at 12 months. This anatomical failure and the lack of follow-up may explain why most patients failed to achieve sustainable weight loss.

Entities:  

Keywords:  Endoscopic revision; Gastric bypass; NOTES; Obesity surgery; ROSE; Revisional surgery

Mesh:

Year:  2015        PMID: 26675939     DOI: 10.1007/s00464-015-4699-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  22 in total

1.  Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain.

Authors:  C C Thompson; J Slattery; M E Bundga; D B Lautz
Journal:  Surg Endosc       Date:  2006-10-05       Impact factor: 4.584

2.  What happens to patients who do not follow-up after bariatric surgery?

Authors:  Jason Harper; Atul K Madan; Craig A Ternovits; David S Tichansky
Journal:  Am Surg       Date:  2007-02       Impact factor: 0.688

3.  Incisionless revision of post-Roux-en-Y bypass stomal and pouch dilation: multicenter registry results.

Authors:  Santiago Horgan; Garth Jacobsen; G Derek Weiss; John S Oldham; Peter M Denk; Frank Borao; Steven Gorcey; Brad Watkins; John Mobley; Kari Thompson; Adam Spivack; Dave Voellinger; Chris Thompson; Lee Swanstrom; Paresh Shah; Greg Haber; Matthew Brengman; Gregory Schroder
Journal:  Surg Obes Relat Dis       Date:  2010-02-13       Impact factor: 4.734

4.  Impact of routine and long-term follow-up on weight loss after laparoscopic gastric bypass.

Authors:  Jon C Gould; Gretchen Beverstein; Susan Reinhardt; Michael J Garren
Journal:  Surg Obes Relat Dis       Date:  2007-10-18       Impact factor: 4.734

5.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

6.  Natural orifice surgery: initial US experience utilizing the StomaphyX device to reduce gastric pouches after Roux-en-Y gastric bypass.

Authors:  Dean Mikami; Bradley Needleman; Vimal Narula; Janice Durant; W Scott Melvin
Journal:  Surg Endosc       Date:  2009-07-25       Impact factor: 4.584

7.  Gastric surgery for morbid obesity. Complications and long-term weight control.

Authors:  C E Yale
Journal:  Arch Surg       Date:  1989-08

8.  Treatment of weight regain after gastric bypass surgery when using a new endoscopic platform: initial experience and early outcomes (with video).

Authors:  Daniel K Mullady; David B Lautz; Christopher C Thompson
Journal:  Gastrointest Endosc       Date:  2009-06-24       Impact factor: 9.427

9.  Early results of trans-oral endoscopic plication and revision of the gastric pouch and stoma following Roux-en-Y gastric bypass surgery.

Authors:  I Michael Leitman; Chiranjiv S Virk; Dimitrios V Avgerinos; Radha Patel; Valentina Lavarias; Burton Surick; John L Holup; Elliot R Goodman; Martin S Karpeh
Journal:  JSLS       Date:  2010 Apr-Jun       Impact factor: 2.172

Review 10.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22
View more
  10 in total

Review 1.  Endoscopic Treatment of Weight Regain Following Roux-en-Y Gastric Bypass: a Systematic Review and Meta-analysis.

Authors:  Vitor Ottoboni Brunaldi; Pichamol Jirapinyo; Diogo Turiani H de Moura; Ossamu Okazaki; Wanderley M Bernardo; Manoel Galvão Neto; Josemberg Marins Campos; Marco Aurélio Santo; Eduardo G H de Moura
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

2.  Laparoscopic Wedge Resection of Gastrojejunostomy for Weight Recidivism after Gastric Bypass.

Authors:  Aly Elbahrawy; Alexandre Bougie; Mohammad Albader; Rajesh Aggarwal; Sebastian Demyttenaere; Amin Andalib; Olivier Court
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

Review 3.  Weight regain after gastric bypass: etiology and treatment options.

Authors:  Almantas Maleckas; Rita Gudaitytė; Rūta Petereit; Linas Venclauskas; Džilda Veličkienė
Journal:  Gland Surg       Date:  2016-12

4.  New endoscopic procedures for diabetes mellitus type 2 and obesity treatment.

Authors:  Francesco Frattini; Giacomo Borroni; Matteo Lavazza; Xiaoli Liu; Hoon Yub Kim; Renbin Liu; Angkoon Anuwong; Stefano Rausei; Gianlorenzo Dionigi
Journal:  Gland Surg       Date:  2016-10

Review 5.  Endoscopic Evaluation and Management of Late Complications After Bariatric Surgery: a Narrative Review.

Authors:  Vivek Kumbhari; Carel W le Roux; Ricardo V Cohen
Journal:  Obes Surg       Date:  2021-07-30       Impact factor: 4.129

Review 6.  Weight loss endoscopy: Development, applications, and current status.

Authors:  Nitin Kumar
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

Review 7.  Endoscopic therapy of weight regain after bariatric surgery.

Authors:  Milutin Bulajic; Salvatore Francesco Vadalà di Prampero; Ivo Boškoski; Guido Costamagna
Journal:  World J Gastrointest Surg       Date:  2021-12-27

Review 8.  Endoscopic Management of Weight Recurrence Following Bariatric Surgery.

Authors:  Donna Maria Abboud; Rebecca Yao; Babusai Rapaka; Rabih Ghazi; Omar M Ghanem; Barham K Abu Dayyeh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

9.  Learning curve of surgical novices using the single-port platform SymphonX: minimizing OR trauma to only one 15-mm incision.

Authors:  Rabi R Datta; Sebastian Schönhage; Thomas Dratsch; Justus Toader; Dolores T Müller; Roger Wahba; Robert Kleinert; Michael Thomas; Georg Dieplinger; Dirk L Stippel; Christiane J Bruns; Hans F Fuchs
Journal:  Surg Endosc       Date:  2020-09-23       Impact factor: 4.584

10.  The use of endoluminal techniques in the revision of primary bariatric surgery procedures: a systematic review.

Authors:  Yan Mei Goh; Nicole Ellen James; En Lin Goh; Achal Khanna
Journal:  Surg Endosc       Date:  2020-02-28       Impact factor: 4.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.